Protein aggregation is the hallmark feature of neurodegenerative diseases. In Parkinson's disease, Alpha-synuclein protein aggregates and accumulates resulting in the formation of Lewy bodies. So far, treatment of PD is only aimed at reducing symptoms. I am exploring various pathways targeting protein aggregation to identify novel therapeutic approaches that are useful in disease modification.
PROTEIN AGGREGATION
& PD
Research Topic
Address:
Dr. Santosh Kumar Guru, Ph.D., Assistant Professor
Room: 64, Department of Biological Sciences (Pharmacology & Toxicology),
National Institute of Pharmaceutical Education and Research (NIPER), An Institute of National Importance,
Department of Pharmaceuticals, Ministry of Chemicals and Fertilizers, GOI.
Balanagar, Hyderabad, Telangana, India-500037